Skip to main content
Clinical Trials/NCT03616600
NCT03616600CompletedNot Applicable

The Safety and Effectiveness of Clinical Performance of Breath-O Correct Orthokeratology Lenses

The Hong Kong Polytechnic University1 site in 1 country31 target enrollmentStarted: March 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
31
Locations
1
Primary Endpoint
Corneal Endothelial Health in Terms of Endothelial Cell Density

Study Overview

Brief Summary

In Hong Kong, approximately 80% of children are myopic by the end of childhood. There is intense interest currently in the potential role of peripheral defocus as a clinical treatment to slow myopia progression. One of the most successful treatments for myopia is orthokeratology. Currently, Breath-O correct lenses are new designed ready-made orthokeratology lenses. This study is to evaluate the safety of wearing this new orthokeratology lens and the effectiveness of clinical performance in young adult.

Detailed Description

Short-sightedness (myopia) is the most common refractive error in the world. In Hong Kong, approximately 80% of children are myopic by the end of childhood. Current treatment strategies to control (i.e. slow) myopia progression in children are primarily designed to harness the natural "emmetropization" process, in which visual feedback from retinal image clarity regulates the rate of eye growth. There is intense interest currently in the potential role of peripheral defocus as a clinical treatment to slow myopia progression, not least since this approach permits clear central vision. One of the most successful treatments for myopia is orthokeratology, which is a therapy of using custom-made rigid gas permeable contact lens. The special design of this contact lens can reshape the corneal profile to minimize the central refractive error while producing beneficial peripheral defocus. Currently, Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material. This study is to evaluate the safety of wearing this new orthokeratology lens and the effectiveness of clinical performance in young adult.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Refractive error: Spherical: normally -1.00D to -4.00D (maximum up to -5.00D); Cylindrical: normally half of Sph (against-the-rule Astigmatism.: lower than -0.75D) (maximum up to -1.50D)
  • •Best corrected Visual acuity: monocular ETDRS 0.0 or better
  • •Ocular health: No ocular abnormality, no contra-indications for overnight orthokeratology lens wear, no refractive surgery
  • •General health: No systemic diseases
  • •Requirement: No history of orthokeratology lens wearing. Agree to participate in this study and willing to wear the orthokeratology lenses overnight in accordance with the instructions given and to come back for follow up within the study period

Exclusion Criteria

  • Not provided

Arms & Interventions

Treatment

Experimental

Wearing the orthokeratology lenses for 3 months

Intervention: Breath-O-Correct Lens (Other)

Control

No Intervention

Not wearing any contact lenses

Outcomes

Primary Outcomes

Corneal Endothelial Health in Terms of Endothelial Cell Density

Time Frame: Baseline, 1st Month, 3rd Month

measured by specular microscope

Corneal Endothelial Health in Terms of Percentage of Variation in Cell Size

Time Frame: Baseline, 1st Month, 3rd Month

measured by specular microscope

Corneal Biomechanics in Terms of Corneal Hysteresis and Resistance Factor

Time Frame: Baseline, 1st Month, 3rd Month

measured by ocular response analyser

Anterior Ocular Surface Evaluation in Terms of Non-invasive Keratography Break-up Time (NIKBUT)

Time Frame: Baseline, 1st Month, 3rd Month

measured by OCULUS Keratograph® 5M

Anterior Ocular Health in Terms of Limbal and Bulbar Redness

Time Frame: Baseline, 1st Month, 3rd Month

measured by OCULUS Keratograph® 5M and graded by JENVIS redness grading system It is a scale of 0 to 4, the higher the score, the more redness the ocular surface manifests

Secondary Outcomes

  • Best Corrected Visual Acuity in Terms of High and Low Contrast(Baseline, 1st Month and the 3rd Month)
  • Reduction of the Refractive Power After Wearing the Breath-O-correct Lens(Baseline, 1st Week, 1st Month, 3rd Month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Henry HL Chan, PhD

Assocaite Professor

The Hong Kong Polytechnic University

Study Sites (1)

Loading locations...

Similar Trials